SCHEMBL17561932

SCHEMBL17561932

CCCCN(C)c1ncc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1-c1ccc(C)nc1

nearest known ligand 0.87

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17561916 0.95 ABL1 (0.84) ABL1
SCHEMBL16860471 0.93 ABL1 (1.00) ABL1
SCHEMBL16860466 0.91 ABL1 (0.90) ABL1
SCHEMBL17561931 0.89 ABL1 (0.88) ABL1
SCHEMBL17561934 0.89 ABL1 (0.74) ABL1
SCHEMBL17561924 0.84 ABL1 (0.87) ABL1
SCHEMBL17561918 0.83 ABL1 (0.77) ABL1
SCHEMBL17561928 0.83 ABL1 (0.71) ABL1
SCHEMBL16860434 0.82 ABL1 (0.88) ABL1
SCHEMBL16860316 0.82 ABL1 (1.00) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278981-B2 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 NOVARTIS AG (CH) 2016-03-08 — — US disclosed
Send feedback